Glenmark Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Mar ' 21

Sales

1,173.81

999.17

1,036.56

1,086.66

967.39

Operating profit

360.25

290.41

288.28

327.79

324.71

Interest

0.80

0.27

0.19

27.78

42.83

Gross profit

366.67

309.65

296.72

306.08

282.60

EPS (Rs)

20.75

17.60

16.54

17.64

202.09

Other income

7.22

19.51

8.63

6.08

0.71

Stock adjustment

-46.50

-60.58

12.39

28.94

-33.69

Raw material

567.62

529.46

499.91

501.66

469.78

Power and fuel

-

-

-

-

-

Employee expenses

114.85

87.83

83.21

85.51

75.13

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

177.60

152.06

152.77

142.77

131.47

Provisions made

-

-

-

-

-

Depreciation

25.74

19.81

19.29

18.58

16.79

Taxation

86.74

74.23

74.82

71.39

67.77

Net profit / loss

254.19

215.61

202.61

216.11

198.05

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

24.51

24.51

24.51

24.51

1.96

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

30.69

29.06

27.81

30.16

33.57

GPM (%)

31.05

30.40

28.39

28.01

29.19

NPM (%)

21.52

21.17

19.39

19.78

20.46